ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,895Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 890

$1.14M Total Retail Price of All Prescriptions

Rank: 32 out of 890

487 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 487 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

19% of this provider’s 487 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 17,633 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 789 681 1 2
SIMVASTATIN 689 649 2 5
OMEPRAZOLE 567 464 3 8
AMLODIPINE BESYLATE 542 472 4 1
NEXIUM 472 357 5 14
POTASSIUM CHLORIDE 454 406 6 11
HYDROCODONE-ACETAMINOPHEN 447 312 S3 7 3
LISINOPRIL 425 349 8 4
FUROSEMIDE 394 325 9 7
GABAPENTIN 362 293 10 12
GLIMEPIRIDE 335 288 11 27
MELOXICAM 326 266 12 18
METFORMIN HCL 324 228 13 6
ATORVASTATIN CALCIUM 288 215 14 13
CARVEDILOL 281 221 15 22
METOPROLOL SUCCINATE 278 203 16 17
PRAVASTATIN SODIUM 277 223 17 10
ZOLPIDEM TARTRATE 263 196 18 19
AMLODIPINE BESYLATE-BENAZEPRIL 243 205 19 41
TRAMADOL HCL 239 204 20 16
CLOPIDOGREL 232 165 21 28
METOPROLOL TARTRATE 222 197 22 15
AZITHROMYCIN 213 166 23 37
HYDROCHLOROTHIAZIDE 201 174 24 9
WARFARIN SODIUM 199 197 25 24
PANTOPRAZOLE SODIUM 199 168 25 34
METFORMIN HCL ER 198 166 27 54
LOSARTAN POTASSIUM 193 187 28 29
CITALOPRAM HBR 182 150 29 20
VENLAFAXINE HCL ER 177 155 30 114
CRESTOR 173 125 31 25
TAMSULOSIN HCL 166 93 32 32
DIOVAN HCT 164 154 33 48
AMITRIPTYLINE HCL 155 143 R 34 43
LYRICA 154 108 35 71
PLAVIX 152 117 36 42
ATENOLOL 149 122 37 23
NIFEDIPINE ER 148 112 38 75
DIGOXIN 140 120 39 65
LISINOPRIL-HYDROCHLOROTHIAZIDE 139 131 40 21
PAROXETINE HCL 138 102 41 68
TORSEMIDE 137 127 42 159
LOSARTAN-HYDROCHLOROTHIAZIDE 134 119 43 57
ONGLYZA 133 114 44 146
DIOVAN 129 94 45 33
CELEBREX 125 100 46 91
COMBIVENT 124 85 47 144
CYMBALTA 119 87 48 45
METHYLPREDNISOLONE 118 89 49 109
CIPROFLOXACIN HCL 117 93 50 58
LIPITOR 114 91 51 77
THEOPHYLLINE ANHYDROUS 112 90 52 243
ALLOPURINOL 112 101 52 31
SERTRALINE HCL 110 96 54 26
ISOSORBIDE MONONITRATE ER 109 80 55 60
PREMARIN 108 96 R 56 105
BENAZEPRIL HCL 101 89 57 44
ADVAIR DISKUS 100 80 58 52
COLCRYS 98 82 59 150
POLYETHYLENE GLYCOL 3350 98 73 59 67
DICLOFENAC SODIUM 98 74 59 96
ROPINIROLE HCL 97 81 62 93
DILTIAZEM ER 93 91 63 129
METOCLOPRAMIDE HCL 92 87 64 125
MECLIZINE HCL 91 53 65 97
SULFAMETHOXAZOLE-TRIMETHOPRIM 91 72 65 76
TRAZODONE HCL 90 65 67 40
LANTUS 88 37 68 50
DONEPEZIL HCL 86 86 69 30
TRAMADOL HCL-ACETAMINOPHEN 86 67 69 117
CLONIDINE HCL 85 62 71 35
SPIRIVA 84 58 72 66
SYNTHROID 84 71 72 53
AMOXICILLIN 83 62 74 94
PROMETHAZINE HCL 82 42 R 75 104
RANITIDINE HCL 81 56 76 49
SPIRONOLACTONE 81 72 76 85
NAMENDA 80 80 78 36
NABUMETONE 80 65 78 143
ATENOLOL-CHLORTHALIDONE 79 56 80 147
VERAPAMIL ER 79 79 80 87
RAMIPRIL 78 62 82 80
MEGESTROL ACETATE 77 68 R 83 92
VESICARE 77 76 83 188
ESTRADIOL 74 64 R 85 118
NAPROXEN 74 57 85 84
DOXEPIN HCL 73 73 87 176
PRIMIDONE 65 63 88 289
FLUTICASONE PROPIONATE 64 36 89 39
TIZANIDINE HCL 62 51 90 106
FEXOFENADINE HCL 61 25 91 272
FLUCONAZOLE 60 34 92 155
GLIPIZIDE 60 51 92 62
TRIAMCINOLONE ACETONIDE 60 35 92 160
ENALAPRIL MALEATE 60 49 92 56
ALPRAZOLAM 59 51 96 95
EXFORGE 59 47 96 140
PROPRANOLOL HCL 58 58 98 141
PROAIR HFA 57 19 99 55
ESCITALOPRAM OXALATE 57 46 99 51
INSULIN SYRINGE 57 37 99 99
KOMBIGLYZE XR 56 37 102 299
VYTORIN 56 44 102 183
MUPIROCIN 55 47 104 121
PEN NEEDLE 55 24 104 135
DOXYCYCLINE HYCLATE 55 40 104 89
BUPROPION HCL SR 54 23 107 216
BUMETANIDE 52 38 108 134
PREDNISONE 50 47 109 47
RISPERIDONE 50 50 109 78
ISOSORBIDE DINITRATE 50 41 109 281
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 6, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.